Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Jasper Therapeutics, Inc. (JSPR) had Weighted-Average Shares Outstanding (Diluted) of 19.17M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-9.10M |
|
-- |
|
-- |
|
$15.84M |
|
$-15.84M |
|
$6.74M |
|
$-9.10M |
|
$-9.10M |
|
$-9.10M |
|
$-9.10M |
|
$-9.10M |
|
$-9.10M |
|
$-15.84M |
|
$-15.55M |
|
19.17M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
19.17M |
$0.33 |
|
$0.33 |
|
| Balance Sheet Financials | |
$34.65M |
|
$0.10M |
|
$1.13M |
|
$35.78M |
|
$13.20M |
|
-- |
|
$18.43M |
|
$31.63M |
|
$4.15M |
|
$4.15M |
|
$4.15M |
|
28.00M |
|
| Cash Flow Statement Financials | |
$-77.16M |
|
$0.01M |
|
$34.21M |
|
$72.05M |
|
$29.11M |
|
$-42.95M |
|
$6.71M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.62 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-77.16M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-219.25% |
|
-219.25% |
|
-25.44% |
|
-219.25% |
|
$0.15 |
|
$-4.03 |
|
$-4.03 |
|